- Home
- CMA vs ELAN Comparison
CMA vs ELAN Comparison
Compare CMA & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMA
- ELAN
- Stock Information
- Founded
- CMA 1849
- ELAN 1954
- Country
- CMA United States
- ELAN United States
- Employees
- CMA N/A
- ELAN N/A
- Industry
- CMA Major Banks
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- CMA Finance
- ELAN Health Care
- Exchange
- CMA Nasdaq
- ELAN Nasdaq
- Market Cap
- CMA 10.0B
- ELAN 10.3B
- IPO Year
- CMA N/A
- ELAN 2018
- Fundamental
- Price
- CMA $76.23
- ELAN $22.90
- Analyst Decision
- CMA Hold
- ELAN Buy
- Analyst Count
- CMA 22
- ELAN 8
- Target Price
- CMA $71.86
- ELAN $20.00
- AVG Volume (30 Days)
- CMA 2.9M
- ELAN 4.8M
- Earning Date
- CMA 10-17-2025
- ELAN 11-05-2025
- Dividend Yield
- CMA 3.71%
- ELAN N/A
- EPS Growth
- CMA 30.50
- ELAN N/A
- EPS
- CMA 5.23
- ELAN 0.88
- Revenue
- CMA $3,234,000,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- CMA $6.48
- ELAN $5.77
- Revenue Next Year
- CMA $3.12
- ELAN $4.96
- P/E Ratio
- CMA $14.63
- ELAN $26.11
- Revenue Growth
- CMA 2.31
- ELAN N/A
- 52 Week Low
- CMA $48.12
- ELAN $8.02
- 52 Week High
- CMA $83.22
- ELAN $22.96
- Technical
- Relative Strength Index (RSI)
- CMA 52.58
- ELAN 72.75
- Support Level
- CMA $76.18
- ELAN $21.80
- Resistance Level
- CMA $78.68
- ELAN $22.86
- Average True Range (ATR)
- CMA 1.93
- ELAN 0.61
- MACD
- CMA -0.40
- ELAN 0.04
- Stochastic Oscillator
- CMA 42.94
- ELAN 97.92
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.